Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 11, 2024

SELL
$24.02 - $43.89 $11,361 - $20,759
-473 Reduced 1.66%
27,994 $1.13 Million
Q3 2023

Oct 16, 2023

SELL
$16.89 - $35.01 $3,006 - $6,231
-178 Reduced 0.62%
28,467 $750,000
Q2 2023

Jul 25, 2023

BUY
$13.29 - $18.01 $380,692 - $515,896
28,645 New
28,645 $492,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.92B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Ziegler Capital Management, LLC Portfolio

Follow Ziegler Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ziegler Capital Management, LLC with notifications on news.